Fluoroquinolone-Resistant Neisseria gonorrhoeae San Diego, California, 1997

Morbidity and Mortality Weekly Report

Volumn 47, Issue 20, 1998, Pages 405-408

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CASE REPORT; CLASSIFICATION; DRUG EFFECT; GONORRHEA; HUMAN; MALE; NEISSERIA GONORRHOEAE; SEROTYPING; UNITED STATES;

ADULT; ANTI-INFECTIVE AGENTS; CALIFORNIA; DRUG RESISTANCE, MICROBIAL; FLUOROQUINOLONES; GONORRHEA; HUMANS; MALE; NEISSERIA GONORRHOEAE; SEROTYPING;

EID: 0032577151     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. CDC. 1998 Guidelines for treatment of sexually transmitted diseases. MMWR 1998;47(no. RR-1).
2. Knapp JS, Fox KK, Trees DL, Whittington WL. Fluoroquinolone resistance in Neisseria gonorrhoeae. Emerging Infectious Diseases 1997;3:33-9.
3. CDC. Fluoroquinolone resistance in Neisseria gonorrhoeae - Colorado and Washington, 1995. MMWR 1995;44:761-4.
4. CDC. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones - Ohio and Hawaii, 1992-1993. MMWR 1994;43:325-7.
5. Fox KK, Knapp JS, Holmes KK, Hook EW III, et al. Antimicrobial resistance in Neisseria gonorrhoeae in the United States, 1988-1994: the emergence of decreased susceptibility to the fluoroquinolones. J Infect Dis 1997;175:1396-403.
6. Knapp JS, Hale JA, Neal SW, Wintersheid K, Rice RJ, Whittington WL. Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin. Antimicrob Agents Chemother 1995;39:2442-5.
7. National Committee for Clinical Laboratory Standards. Approved standard M7-A3: methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1993.
8. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. M100-S8. Wayne, Pennsylvania: National Committee for Clinical Laboratory Standards, 1998.
9. Aplasca MR, Pato-Mesola V, Klausner J, Tuazon C, et al. High rates of failure after treatment with ciprofloxacin - are fluoroquinolones no longer useful for gonorrhea treatment? [Abstract] In: Abstracts of the 4th International Congress on AIDS in Asia and the Pacific; October 1997; Manila, Philippines.